Kapil Dhingra

Insider Reports History

Entity
Individual
Location
39 Bliss Avenue, Tenafly, New Jersey
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kapil Dhingra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Director Stock Option (right to buy) 32 K Apr 1, 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30.6 K Jun 6, 2024 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 11.9 K Jun 4, 2024 Direct

Insider Reports Filed by Kapil Dhingra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Apr 15, 2024 1 $0 4 Apr 17, 2024 Director
CRGX CARGO Therapeutics, Inc. Apr 15, 2024 0 $0 3 Apr 17, 2024 Director
REPL Replimune Group, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
REPL Replimune Group, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
REPL Replimune Group, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director